Q4 total sales grew 11%, and comparable store sales increased 4% Q4 net income was $310 million, and diluted EPS was $4.84 FY25 total sales grew ...
Rigetti Computing, Inc. (Nasdaq: RGTI) ("Rigetti" or the "Company"), a pioneer in full-stack quantum-classical computing, today announced its financial results for the fourth quarter and year ended ...
CubeSmart (NYSE: CUBE) today announced its operating results for the three and twelve months ended December 31, 2025. "Recent results reinforce our view that we have reached an inflection point as ...
Two bills designed to enforce federal immigration policy through SNAP and Medicaid have been approved by the Oklahoma House ...
This press release is not intended for UK mediaHERNEXEOS® (zongertinib tablets) approved based on an objective response rate of 76% (N=72) as ...
Q4 2025 Adjusted EBITDA was $281 million, compared to Adjusted EBITDA of $16 million in Q4 2024 Q4 2025 net income attributable to IEP was $1 million, compared to a net loss of $98 million in Q4 2024 ...
Three medical providers at a Rogers Behavioral Health clinic in West Allis were fired on Feb. 9, days after formally declaring they wanted to form a union, according to two of them. The three were ...
Scale continuously determines where freight is needed to balance carrier networks and deploys intelligent autonomous ...
Intel-exit founder and 18-patent inventor joins Avatier board to advance Trusted Conversational AI for Identity at ...
Pancreatic cancer has a lot of nerve. Notoriously tricky to detect, the disease also often resists traditional therapy. So, researchers are urgently looking for new ways to disrupt tumor formation.
Reported positive initial Phase 1b data for ELVN-001 in CML Initiation of the Phase 3 ENABLE-2 pivotal trial of ELVN-001 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results